API PORTFOLIO

Hovione helps you bring new medicines to patients in an unprecedented speed.

As a fully integrated CDMO, we offer over 60 years’ experience in chemical process development and manufacture of APIs. Our more recent capabilities in Drug Product together with our innovative science, the most up-to-...

Hovione is the leader in Spray Drying, thanks to the largest capacity, the best scale-up science and the most experienced team.

Spray drying is a continuous process that can be used for multiple applications. Over the last 15 years, the technology has been used for the production of solid ...

At Hovione we can tailor-make particle size distributions through complex particle engineering technologies, like wet-polishing and monosep, in ranges suitable for inhalation and incorporate desired morphology characteristics into your API. We are also able to start with a Hovione-produced API and develop ...

High value applications Hovione provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.
• Branded generics where quality and security of supply is paramount • Difficult to make AB rated generics such as nasal and inhalation products where devel...

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.

Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.